← Back to screener

Structure Therapeutics Inc. GPCR

Rank #1384 · Nasdaq · $4.7B market cap
Audited by Ernst & Young LLP, no going-concern flag in the latest filing.
Score
49.1
P/E
-52.0
P/B
-40.50
ROE
77.8%
Op. Margin
–%
Debt Ratio
-33%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆
Poor

P/E -52.0x, P/B -40.50x. Ranks in the top 85% of the universe.

Profitability ★★★★★
Excellent

ROE 77.8%. Ranks in the top 5% of the universe.

Safety ★★★★★
Excellent

Debt ratio -33%. Ranks in the top 7% of the universe. Under 100% is generally considered a safe level.

Growth –
No data

Not enough historical filings to compute year-over-year growth yet.

Profitability is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2023–$-0.1B$-0.1B$-0.1B–-20
2024–$-0.1B$-0.1B$-0.1B–-25
2025–$-0.1B$-0.1B$-0.1B–-33

← See the full screener